CONTRAINDICATION
AURYXIA® (ferric citrate) is contraindicated in patients with iron overload syndromes, e.g., hemochromatosis
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
The most common adverse reactions reported with AURYXIA in clinical trials were:
SPECIFIC POPULATIONS
DRUG INTERACTIONS
When clinically significant drug interactions are expected, e.g., Ciprofloxacin or Doxycycline, separate timing of administration.
INDICATION
AURYXIA® (ferric citrate) is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis
To report suspected adverse reactions, contact Akebia Therapeutics, Inc. at 1-844-445-3799
Please see full Prescribing Information
CONTRAINDICATION
AURYXIA® (ferric citrate) is contraindicated in patients with iron overload syndromes, e.g., hemochromatosis
WARNINGS AND PRECAUTIONS
ADVERSE REACTIONS
The most common adverse reactions reported with AURYXIA in clinical trials were:
SPECIFIC POPULATIONS
DRUG INTERACTIONS
When clinically significant drug interactions are expected, e.g., Ciprofloxacin or Doxycycline, separate timing of administration.
INDICATION
AURYXIA® (ferric citrate) is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis
To report suspected adverse reactions, contact Akebia Therapeutics, Inc. at 1-844-445-3799
Please see full Prescribing Information